#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Acute myeloid leukaemia Neoplasm malignant Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Ovarian cancer Colorectal cancer Hepatocellular carcinoma Dermatitis atopic Dementia Alzheimer's type Asthma Breast cancer metastatic Type 2 diabetes mellitus Non-small cell lung cancer metastatic More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Squamous cell carcinoma of the vulva Glioma Extra-osseous Ewing's sarcoma recurrent Angiosarcoma metastatic Growth hormone deficiency Spinal cord injury cervical Extranodal marginal zone B-cell lymphoma (MALT type) Myocarditis Neonatal asphyxia Lymphatic malformation Cognitive disorder Prader-Willi syndrome Hodgkin's disease recurrent Osteosarcoma metastatic Central nervous system lymphoma More trials…

    Learn about Rare Diseases

    Langerhans cell sarcoma Acquired haemophilia – Trials in Disease Gaucher’s disease type I – Trials in Disease Rhabdomyosarcoma recurrent – Trials in Disease Chordoma – Treatment Skin angiosarcoma Haemophilia A without inhibitors – Life with Disease Hairy cell leukaemia recurrent – Life with Disease Ewing’s sarcoma recurrent – Trials in Disease Usher’s syndrome – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Vgl101 Azd3427 Atropine Sulfate Monohydrate Vafidemstat Artemisia Vulgaris (312) VELPATASVIR Tralokinumab Nitrogen Levomepromazine Hydrochloride Cariprazine Hydrochloride Ganaxolone Luspatercept Furosemide Ph. Eur. Dalteparin Sodium Farletuzumab Ecteribulin Hydrocortisone Hemisuccinate Db-Oto-5 Davutamig Catequentinib Dihydrochloride Pamidronate Disodium More therapies…

    Learn about Your Condition

    Pharyngeal cancer stage I Rheumatic disorder Tetanus Hand fracture Multiple sclerosis relapse Bile duct adenocarcinoma Cognitive disorder Autoimmune haemolytic anaemia Hyperglycaemia Paresis Endometrial cancer stage I Plasma cell myeloma recurrent Respiratory tract infection Peritonitis Skin wrinkling More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden
  1. Clinicaltrials.eu/
  2. Centre Hospitalier Victor Dupouy

Centre Hospitalier Victor Dupouy

69 Rue Du Lieutenant Colonel Prudhon, Argenteuil, 95107, France

Want to learn more about this study or check if you can participate? Contact us.

  • Study on Hydrocortisone and Fludrocortisone for Adults with Critical Illness-Related Corticosteroid Insufficiency

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Critical illness
    Investigated Drugs:
    • Hydrocortisone Hemisuccinate
    • Tetracosactide
    • Fludrocortisone Acetate
    France

  • Study comparing dexamethasone versus immunoglobulin plus prednisone for adults with immune thrombocytopenia (ITP) who have moderate to severe bleeding

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Immune thrombocytopenia
    Investigated Drugs:
    • Dexamethasone
    • Human Normal Immunoglobulin (Iv)
    • Prednisolone
    France

  • Study Comparing Brentuximab Vedotin with Drug Combination for Treating Advanced Classical Hodgkin Lymphoma in Patients

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Bleomycin
    • Dacarbazine
    • Brentuximab Vedotin
    Belgium Czechia Denmark France Hungary Italy +3

  • Study on AON-D21 for Patients with Severe Community-Acquired Pneumonia in Intensive Care

    Not recruiting

    2 1
    Investigated Drugs:
    • Aon-D21
    Belgium France Germany Spain

  • Study on the Effects of Rusfertide (PTG-300) for Patients with Polycythemia Vera

    Not recruiting

    3 1
    Investigated Diseases:
    • Polycythaemia vera
    Investigated Drugs:
    • Rusfertide
    Austria Belgium Czechia France Germany Hungary +5

  • Study on the Safety and Effectiveness of TIN816 for Patients with Sepsis-Related Acute Kidney Injury

    Not recruiting

    2 1
    Investigated Diseases:
    • Acute kidney injury
    • Sepsis
    Investigated Drugs:
    • Tin816
    Austria Belgium Czechia France Germany Hungary +2

  • Study Comparing Zanubrutinib with Bendamustine and Rituximab for Patients with Untreated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Rituximab
    • Venetoclax
    • Zanubrutinib
    Austria Belgium Czechia France Italy Poland +2

  • Study on the Safety of Salbutamol Inhalers with Propellants HFA-152a and HFA-134a for Adults with Asthma

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Salbutamol Sulfate
    France Greece Italy Poland Spain

  • Study Comparing Ibrexafungerp and Fluconazole for Treating Candidemia or Invasive Candidiasis in Patients

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Systemic candida
    Investigated Drugs:
    • Clotrimazole
    • Ibrexafungerp
    • Fluconazole
    Belgium Bulgaria France Germany Greece Italy +1

  • Study of ribociclib combined with hormone therapy for patients with early-stage hormone receptor-positive, HER2-negative breast cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Hormone receptor positive breast cancer
    • Breast cancer
    Investigated Drugs:
    • Goserelin
    • Anastrozole
    • Letrozole
    Austria Belgium France Germany Hungary Ireland +4
Previous Page
1 … 5 6 7 8 9
Next Page

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!